Inhibitor Therapeutics, Inc. (INTI) shareholders
INTIOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.11+0.00 (+0.09%)
Close on Oct 19, 2026Market cap $19.06MP/E –Yield –
Ownership
Who owns Inhibitor Therapeutics's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Francis E. Odonnell Jr | Chief Executive Officer, Director, 10% owner | 85,777,069 | 49.36% | Aug 4, 2026 |
| James A. McNulty | Chief Financial Officer | 46,002,114 | 26.47% | Aug 4, 2026 |
| Michelle Yanez | Director | 1,221,271 | 0.70% | Aug 4, 2026 |
| Samuel P. Sears Jr | Director | 1,229,543 | 0.71% | Aug 4, 2026 |
| Ronald E. Osman | Director, 10% owner | 23,554,985 | 13.55% | Aug 4, 2026 |
| Michael Allen Jerman | Director | 180,411 | 0.10% | Jun 24, 2026 |
| Niraj Vasisht | Director | 200,000 | 0.12% | Jun 1, 2026 |
| Ronald E. Osman Irrevocable Trust III under Agreement dated May 13, 2012 | 10% owner | 47,104,970 | 27.10% | Aug 4, 2026 |
| Robe Capital LLC Black | 10% owner | 20,101,057 | 11.57% | Aug 4, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| James A. McNulty Chief Financial Officer | Jul 1, 2026 | Gift | −3,200,000 | – | – | 19,901,057 |
| Niraj Vasisht Director | May 5, 2026 | Award | +50,000 | – | – | 200,000 |
| Francis E. Odonnell Jr Chief Executive Officer, Director, 10% owner | May 4, 2026 | Award | +50,000 | – | – | 150,000 |
| Michelle Yanez Director | May 4, 2026 | Award | +50,000 | – | – | 1,221,271 |
| Ronald E. Osman Irrevocable Trust III under Agreement dated May 13, 2012 10% owner | May 4, 2026 | Award | +50,000 | – | – | 23,614,985 |
| Samuel P. Sears Jr Director | May 4, 2026 | Award | +50,000 | – | – | 1,229,543 |
| Michael Allen Jerman Director | May 4, 2026 | Award | +50,000 | – | – | 180,411 |
| Niraj Vasisht Director | Apr 1, 2025 | Award | +50,000 | – | – | – |
| Ronald E. Osman Director, 10% owner | Apr 1, 2025 | Award | +50,000 | – | – | 23,554,985 |
| Michelle Yanez Director | Apr 1, 2025 | Award | +50,000 | – | – | 896,271 |
| Michael Allen Jerman Director | Apr 1, 2025 | Award | +50,000 | – | – | 80,411 |
| Samuel P. Sears Jr Director | Apr 1, 2025 | Award | +50,000 | – | – | 1,279,543 |
| James A. McNulty Chief Financial Officer | Dec 2, 2024 | Gift | +1,000,000 | – | – | 1,946,135 |
| Michelle Yanez Director | Dec 2, 2024 | Gift | +250,000 | – | – | 1,146,271 |
| Michelle Yanez Director | Apr 1, 2024 | Award | +50,000 | – | – | 896,271 |
| Ronald E. Osman Irrevocable Trust III under Agreement dated May 13, 2012 10% owner | Apr 1, 2024 | Award | +50,000 | – | – | 23,564,985 |
| Samuel P. Sears Jr Director | Apr 1, 2024 | Award | +50,000 | – | – | 1,129,543 |
| Michael Allen Jerman Director | Apr 1, 2024 | Award | +50,000 | – | – | 80,411 |
| Ronald E. Osman Irrevocable Trust III under Agreement dated May 13, 2012 10% owner | Aug 11, 2023 | Award | +25,000 | – | – | 23,514,985 |
| James A. McNulty See Remarks, 10% owner | May 5, 2023 | Other | +398,135 | – | – | 946,135 |
| James A. McNulty See Remarks, 10% owner | May 5, 2023 | Other | −79,627,069 | – | – | 0 |
| James A. McNulty See Remarks, 10% owner | May 5, 2023 | Other | +20,101,057 | – | – | 26,101,057 |
| Michelle Yanez Director | May 5, 2023 | Other | +796,271 | – | – | 800,673 |
| Pharma International Pty Ltd Mayne 10% owner | Jan 15, 2021 | Other | +2,240,488 | – | – | 204,083,227 |
| Pharma International Pty Ltd Mayne 10% owner | Jul 15, 2020 | Other | +3,189,688 | – | – | 201,842,739 |
| W. Mark Watson Director | Dec 12, 2019 | Buy | +500 | $0.06 | $30 | 1,054,100 |
| Garrison J. Hasara CFO and Treasurer | Dec 2, 2019 | Buy | +13,500 | $0.07 | $945 | 3,972,544 |
| Pharma International Pty Ltd Mayne 10% owner | Jan 15, 2019 | Other | +362,121 | – | – | 198,653,051 |
| E. Brendan Magrab Director | Dec 20, 2018 | Award | +65,000 | $0.08 | $5.20K | 65,000 |
| Robert Daniel Martin Director | Dec 20, 2018 | Award | +60,000 | $0.08 | $4.80K | 116,000 |
| Garrison J. Hasara CFO and Treasurer | Aug 30, 2018 | Sale | −100,000 | $0.27 | $27.00K | 3,959,044 |
| Pharma Ventures Pty Ltd Mayne 10% owner | Jul 15, 2018 | Other | +184,798 | – | – | 198,290,930 |
| Pharma International Pty Ltd Mayne 10% owner | Dec 19, 2017 | Buy | +600,000 | $162660.00 | $97.60B | 198,106,132 |
| Stefan Cross Director | Dec 19, 2017 | Buy | −600,000 | $162660.00 | $97.60B | 0 |
| HedgePath, LLC 10% owner | Jun 30, 2017 | Sale | −2,500,000 | – | – | 79,627,069 |
| Nicholas J. Virca President and CEO | Mar 8, 2017 | Tax withholding | −6,314,219 | $0.34 | $2.15M | 8,727,519 |
| Nicholas J. Virca President and CEO | Mar 8, 2017 | Option exercise | +15,041,738 | – | – | 15,041,738 |
| Stefan Cross Director | Mar 8, 2017 | Option exercise | +300,000 | – | – | 600,000 |
| Stefan Cross Director | Mar 8, 2017 | Option exercise | +300,000 | – | – | 300,000 |
| Richard Dana Ono Director | Mar 8, 2017 | Option exercise | +300,000 | – | – | 300,000 |
| Richard Dana Ono Director | Mar 8, 2017 | Tax withholding | −118,800 | $0.34 | $40.39K | 181,200 |
| Richard Dana Ono Director | Mar 8, 2017 | Tax withholding | −118,800 | $0.34 | $40.39K | 362,400 |
| Richard Dana Ono Director | Mar 8, 2017 | Option exercise | +300,000 | – | – | 481,200 |
| Richard Dana Ono Director | Mar 8, 2017 | Option exercise | +150,000 | – | – | 512,400 |
| Richard Dana Ono Director | Mar 8, 2017 | Tax withholding | −59,400 | $0.34 | $20.20K | 453,000 |
| Garrison J. Hasara CFO and Treasurer | Mar 8, 2017 | Tax withholding | −1,470,478 | $0.34 | $499.96K | 2,029,522 |
| Garrison J. Hasara CFO and Treasurer | Mar 8, 2017 | Option exercise | +3,500,000 | – | – | 5,529,522 |
| Garrison J. Hasara CFO and Treasurer | Mar 8, 2017 | Tax withholding | −1,470,478 | $0.34 | $499.96K | 4,059,044 |
| Garrison J. Hasara CFO and Treasurer | Mar 8, 2017 | Option exercise | +3,500,000 | – | – | 3,500,000 |
| W. Mark Watson Director | Mar 8, 2017 | Tax withholding | −79,200 | $0.34 | $26.93K | 553,600 |
| W. Mark Watson Director | Mar 8, 2017 | Option exercise | +200,000 | – | – | 632,800 |
| W. Mark Watson Director | Mar 8, 2017 | Tax withholding | −158,400 | $0.34 | $53.86K | 432,800 |
| W. Mark Watson Director | Mar 8, 2017 | Option exercise | +400,000 | – | – | 591,200 |
| W. Mark Watson Director | Mar 8, 2017 | Option exercise | +300,000 | – | – | 310,000 |
| W. Mark Watson Director | Mar 8, 2017 | Tax withholding | −118,800 | $0.34 | $40.39K | 191,200 |
| Pharma International Pty Ltd Mayne 10% owner | Nov 15, 2016 | Option exercise | +4,750,569 | – | – | 192,645,799 |
| Pharma International Pty Ltd Mayne 10% owner | Nov 15, 2016 | Option exercise | +4,860,000 | – | – | 197,506,132 |
| Pharma International Pty Ltd Mayne 10% owner | Nov 15, 2016 | Option exercise | +333 | – | – | 192,646,132 |
| Pharma International Pty Ltd Mayne 10% owner | Nov 4, 2016 | Option exercise | +33,333,000 | – | – | 187,895,230 |
| Pharma International Pty Ltd Mayne 10% owner | Nov 4, 2016 | Option exercise | +5,500,000 | – | – | 154,562,230 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
–
Short volume, 0 days
–
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Inhibitor Therapeutics's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?